Skip to main content
. Author manuscript; available in PMC: 2015 Mar 27.
Published in final edited form as: Am J Transplant. 2008 Oct 6;8(12):2668–2673. doi: 10.1111/j.1600-6143.2008.02430.x

Table 1.

Patient demographics, mean serum PSA and mean serum creatinine levels by immunosuppressive regimen

Sirolimus group (n = 19) Tacrolimus group (n = 78) p-Value
African American n (%) 1 (5.3%) 5 (6.4%) 0.88
Mean age (years) (95% CI) 60.0 (56.2–62.5) 57.9 (58.2–60.9) 0.21
Mean BMI (95% CI) 25.3 (22.7–27.5) 25.6 (24.3–26.1) 0.88
Mean posttransplant serum Cr level (mg/dL) (95% CI) 1.8 (1.5–2.0) 1.6 (1.5–1.7) 0.22
Mean pretransplant PSA (ng/mL) (95% CI) 1.8 (1.3–2.2) 1.7 (1.5–1.9) 0.89
Mean posttransplant PSA (ng/mL) (95% CI) 0.9 (0.7–1.2) 1.9 (1.7–2.1) <0.001

CI = confidence interval; BMI = body mass index; PSA = prostate-specific antigen.